Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Jinhua Xu, Xiaodong Bi et al.|Journal of the American Academy of Dermatology|2024Cited by 28